Lithium Quantitative Testing Drug - Vietnam Registration 240002058/PCBB-HCM
Access comprehensive regulatory information for Lithium Quantitative Testing Drug in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TBYT Loแบกi B medical device is registered under number 240002058/PCBB-HCM and manufactured by Siemens Healthcare Diagnostics Inc.. The authorized representative in Vietnam is CรNG TY TNHH SIEMENS HEALTHCARE.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Siemens Healthcare Diagnostics Inc., and 1 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
240002058/PCBB-HCM
000.00.19.H29-240828-0041
Atellica CH LITH_2
11532401
Technical Details
On Atellica CH analyzer: The Atellica CH Lithium_2 (LITH_2) test is used for in vitro diagnosis in the quantification of lithium in human serum and plasma (natri heparin, kali EDTA) using the Atellica CH Analyzer. This test is used to support the monitoring of lithium therapy. On Atellica CI analyzer: The Atellica CH Lithium_2 (LITH_2) test is used for in vitro diagnosis to quantify lithium in human serum and plasma (natri heparin, kali EDTA) using the Atellica CI Analyzer. This test is used to support the monitoring of lithium therapy.
Dates and Status
Sep 11, 2024